Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03470805||Recruiting||Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma||
||Other / Industry||
||66||Female||18 Years and older (Adult, Older Adult)||NCT03470805||OLATRA
|June 21, 2018||June 2021||June 2021||March 20, 2018||January 29, 2019||